TY - JOUR
T1 - Prescriptions for atopic dermatitis
T2 - oral corticosteroids remain commonplace
AU - Alexander, Tiffany
AU - Maxim, Elena
AU - Cardwell, Leah A.
AU - Chawla, Aneesh
AU - Feldman, Steven R.
N1 - Funding Information:
Dr. Feldman has received research, speaking and/or consulting support from a variety of companies including Galderma, GSK/ Stiefel, Almirall, Leo Pharma, Baxter, Boeringer Ingelheim, Mylan, Celgene, Pfizer, Valeant, Abbvie, Cosmederm, Anacor, Astellas, Janssen, Lilly, Merck, Merz, Novartis, Qurient, National Biological Corporation, Caremark, Advance Medical, Suncare Research, Informa, UpToDate and National Psoriasis Foundation. Tiffany Alexander, Elena Maxim, Leah Cardwell and Aneesh Chawla have no conflicts to disclose.
Publisher Copyright:
© 2017 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2018/4/3
Y1 - 2018/4/3
N2 - Introduction: Atopic dermatitis (AD) is a common, chronic inflammatory skin disease characterized by pruritic, often lichenified, patches and plaques. Methods: Data were obtained from the Humana database, a large claim-based database encompassing more than 20 million patients under a commercial healthcare insurance plan. Our cohort included 39,526 subjects who saw a dermatologist for a primary ICD-9 diagnosis of atopic dermatitis (691.8) between the years of 2010 and 2015. Subjects were stratified according to gender, age and race. Prescribed medication lists were obtained and sorted based on potential indication for atopic dermatitis. Results: The most common medications prescribed for atopic dermatitis in descending order were topical corticosteroids (60.2% of patients), oral antibiotics (17.3% of patients), antifungals (6.7% of patients), antihistamines (6.4% of patients), oral corticosteroids (5.9% of patients), calcineurin inhibitors (2.3% of patients) and emollients (1.2% of patients). Males ages 20–39 and 40–59 had the highest rates of oral steroids prescribed, at 9.2% and 9.8% of patients, respectively. Conclusions: Presumably, individuals who are prescribed multiple courses of oral corticosteroids over time have severe atopic dermatitis with recalcitrance to other options. Given the side effect profile of oral corticosteroids, steroid-sparing systemic agents may be a better long-term option in the absence of contraindications.
AB - Introduction: Atopic dermatitis (AD) is a common, chronic inflammatory skin disease characterized by pruritic, often lichenified, patches and plaques. Methods: Data were obtained from the Humana database, a large claim-based database encompassing more than 20 million patients under a commercial healthcare insurance plan. Our cohort included 39,526 subjects who saw a dermatologist for a primary ICD-9 diagnosis of atopic dermatitis (691.8) between the years of 2010 and 2015. Subjects were stratified according to gender, age and race. Prescribed medication lists were obtained and sorted based on potential indication for atopic dermatitis. Results: The most common medications prescribed for atopic dermatitis in descending order were topical corticosteroids (60.2% of patients), oral antibiotics (17.3% of patients), antifungals (6.7% of patients), antihistamines (6.4% of patients), oral corticosteroids (5.9% of patients), calcineurin inhibitors (2.3% of patients) and emollients (1.2% of patients). Males ages 20–39 and 40–59 had the highest rates of oral steroids prescribed, at 9.2% and 9.8% of patients, respectively. Conclusions: Presumably, individuals who are prescribed multiple courses of oral corticosteroids over time have severe atopic dermatitis with recalcitrance to other options. Given the side effect profile of oral corticosteroids, steroid-sparing systemic agents may be a better long-term option in the absence of contraindications.
KW - eczema
KW - steroid sparing
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=85046133844&partnerID=8YFLogxK
U2 - 10.1080/09546634.2017.1365112
DO - 10.1080/09546634.2017.1365112
M3 - Article
C2 - 28789575
AN - SCOPUS:85046133844
SN - 0954-6634
VL - 29
SP - 238
EP - 240
JO - Journal of Dermatological Treatment
JF - Journal of Dermatological Treatment
IS - 3
ER -